Related Experiment Video
Updated: Jun 20, 2026

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses
Published on: April 4, 2019
Respiratory syncytial virus (RSV) prevention and treatment: past, present, and future
1Baylor College of Medicine, and, Perinatal Center, Texas Children's Hospital, Houston, TX 77030, USA. lweisman@bcm.edu
Insights
Respiratory syncytial virus (RSV) poses a significant global health threat, particularly to infants. This review covers past, present, and future prevention and treatment strategies for high-risk populations.
Area of Science:
- Virology
- Pediatrics
- Infectious Diseases
Background:
- Respiratory syncytial virus (RSV) is a major global pathogen causing recurrent infections throughout life.
- Infants, especially those with pre-existing conditions, face significant morbidity and mortality from RSV.
- Current treatments are limited, necessitating research into novel interventions.
Purpose of the Study:
- To review the clinical aspects of RSV, focusing on high-risk infant populations.
- To examine existing, emerging, and future prevention and treatment strategies for RSV in these vulnerable groups.
- To serve as a comprehensive resource for clinicians and researchers.
Main Methods:
- Literature review of clinical studies and research on RSV.
- Analysis of current and pipeline therapeutic and prophylactic agents.
- Focus on evidence-based strategies for high-risk infant populations.
Main Results:
- Limited efficacy of current RSV treatments like Ribavirin.
- Several novel therapeutic agents (e.g., RSV604, BTA9881, ALN-RSV01) are under investigation.
- Established and developing preventive strategies (e.g., palivizumab, motavizumab, Medi-557) exist.
Conclusions:
- RSV remains a critical concern, especially for high-risk infants.
- A range of preventive and therapeutic options are evolving.
- This review consolidates information on RSV management for clinicians and investigators.
Abstract:
Respiratory syncytial virus (RSV) is a very important pathogen worldwide. It occurs and recurs naturally throughout life. Both short and long term morbidity, and mortality are particularly significant for infants, especially those infants with underlying conditions and risk factors. Current treatment strategies for these patients (e.g Ribavirin) are limited but several new interventions (e.g. RSV604, BTA9881, ALN-RSV01) are under investigation. Several preventive agents and strategies have been developed (e.g. RSV-IGIV, palivizumab) and others are in the pipeline (e.g. motavizumab) and under development (e,g, Medi-557). In this article, we review the RSV clinical condition with a focus on the highest risk populations. In addition we review prevention and treatment strategies of the past, present and future for these high-risk patients. This review should provide a single valuable source of information to clinicians and investigators.
More Related Videos
Related Concept Videos
Respiratory Syncytial Virus Disease
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Common Respiratory Disorders
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...

